Britain's FTSE 100 rose on Wednesday as investors weighed positive inflation data ahead of key central bank meetings in the U ...

Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been ...

Hepatitis B is the most widespread serious liver infection globally, caused by the hepatitis B virus (HBV), which targets and ...

At ASCO 2025, an expert discusses encouraging new early-phase research in clinical trials on treating myeloma.

The stock of Sigachi Industries tanked 6.88 per cent, Shilpa Medicare dropped 4.92 per cent, Suven Life Sciences declined ...

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

The chronic hepatitis B market size is predicted to surge owing to the increasing prevalence of the disease globally and rising awareness about early diagnosis and treatment. Advances in antiviral ...

Based in Kuala Lumpur, Aman brings over two decades of HR experience across industries like finance and pharma. To him, ...

Identifying good mid cap stocks from hundreds of options is no easy feat. Luckily, we've done the hard work for you.

A new biotech has come roaring to life in Wales with a $140 million series A and a lead candidate ready for phase 2 trials in ...